Actemra IV (tocilizumab) - Roche, JW Pharma, Chugai Pharmaceutical
Brukinsa (zanubrutinib) - BeOne Medicines
Lunsumio (mosunetuzumab-axgb) - Roche
http://clinicaltrials.gov/ct2/show/NCT06492837
 
Sep 12, 2026
 
Prev Next